Come up with a name for your new list and we'll add to it:
Tau Therapeutics raised a round of funding on February 06, 2006. Investors include
CIT GAP Funds.
Tau Therapeutics is a clinical stage company developing oncology drugs for solid tumors that selectively inhibit the T-type calcium channel - a mechanism of action for cancer. The company's approach, …